✦ LIBER ✦
Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia
✍ Scribed by Shimoni, A; Leiba, M; Schleuning, M; Martineau, G; Renaud, M; Koren-Michowitz, M; Ribakovski, E; le Coutre, P; Arnold, R; Guilhot, F
- Book ID
- 109886515
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 103 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.